Financial Advocates Investment Management’s Illumina ILMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-2,522
Closed -$942K 788
2021
Q1
$942K Buy
+2,522
New +$1.03M 0.07% 330
2020
Q4
Sell
-914
Closed -$275K 732
2020
Q3
$275K Sell
914
-48
-5% -$16.5K 0.02% 494
2020
Q2
$347K Buy
962
+25
+3% +$8.04K 0.03% 434
2020
Q1
$249K Sell
937
-20
-2% -$5.59K 0.04% 390
2019
Q4
$309K Sell
957
-103
-10% -$31.2K 0.03% 389
2019
Q3
$314K Buy
1,060
+432
+69% +$127K 0.04% 369
2019
Q2
$225K Buy
+628
New +$198K 0.03% 425

Other funds holding ILMN

Financial Advocates Investment Management's ILMN Position: Q2 2021 in Review

Financial Advocates Investment Management sold out of Illumina (ILMN) in Q2 2021, closing a stake of 2,522 shares — an estimated $942K sold.

Financial Advocates Investment Management first reported a position in ILMN in Q2 2019 and held it in 7 quarters. The position peaked at $942K in Q1 2021. 1,069 funds tracked by Wall St. Rank hold ILMN as of Q2 2021.

  • Financial Advocates Investment Management reported no remaining Illumina position as of Q2 2021 after selling out during the quarter.
  • Financial Advocates Investment Management sold 2,522 Illumina shares in Q2 2021, an estimated $942K.
  • Financial Advocates Investment Management first reported a position in Illumina in Q2 2019 and held it in 7 quarters.
  • Financial Advocates Investment Management's Illumina position peaked at $942K in Q1 2021.
  • 1,069 funds tracked by Wall St. Rank held Illumina as of Q2 2021.

Based on Financial Advocates Investment Management's 13F filing for Q2 2021, filed 3 Aug 2021.